Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532135) titled 'Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer' on April 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Chulalongkorn University
Condition:
Healthy Volunteers
Non Diabetic Hyperglycemia
Intervention:
Combination Product: Mulberry Leaf Extract
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: October 1, 2025
Target Sample Size: 48
Countries of Recruitment:
Thailand
To know more...